Fred Kurland's Net Worth

$2.75 Million

Estimate Recalculated Dec 4, 2025 01:11AM EST

Who is Fred Kurland

Fred Kurland has an estimated net worth of $2.75 Million. This is based on reported shares across multiple companies, which include XOMA LTD /DE/, CORCEPT THERAPEUTICS INC, Aridis Pharmaceuticals, Inc., and GENITOPE CORP.

SEC CIK

Fred Kurland's CIK is 0001267273

Past Insider Trading and Trends

2011 was Fred Kurland's most active year for acquiring shares with 5 total transactions. Fred Kurland's most active month to acquire stocks was the month of January. 2015 was Fred Kurland's most active year for disposing of shares, totalling 14 transactions. Fred Kurland's most active month to dispose stocks was the month of March. 2014 saw Fred Kurland paying a total of $534,600.00 for 155,983 shares, this is the most they've acquired in one year. In 2013 Fred Kurland cashed out on 74,720 shares for a total of $77,195.08, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

XOMA Corp

CFO & VP Finance
Updated Apr 07, 2015
Form 4
-31.86%
-35.27K
$3.61
-$127.25K
Apr 07, 2015
102.85K
Options
Apr 06
Form 4
-8.20%
-9.16K
$4.01
-$36.75K
Mar 20, 2015
129.94K
Options
Mar 18
Form 4
14.47%
10.00K
Mar 02, 2015
106.48K
Grant
Feb 26
Form 4
-18.80%
-16.00K
Feb 04, 2015
93.48K
Grant
Feb 03
Form 4
-9.01%
-8.77K
$3.89
-$34.15K
Nov 17, 2014
113.01K
Sale
Nov 13
Form 4
-9.65%
-10.40K
$4.31
-$44.78K
Aug 19, 2014
121.78K
Sale
Aug 14 - Aug 15
Form 4
-8.08%
-5.92K
$6.32
-$37.36K
Mar 20, 2014
91.65K
Sale
Mar 18
Form 4
728.92%
103.45K
$8.91
$534.60K
Mar 03, 2014
142.03K
Grant
Feb 27
Form 4
-34.59%
-7.64K
Feb 10, 2014
36.84K
Grant
Feb 07
Form 4
-24.69%
-12.33K
$3.91
-$48.24K
Nov 15, 2013
60.01K
Sale
Nov 13
Form 4
-29.33%
-20.73K
$3.86
Aug 16, 2013
72.34K
Sale
Aug 14 - Aug 15
Form 4
77.68K
$2.72
$122.32K
Mar 01, 2013
77.68K
Grant
Feb 28
Form 4
-13.44%
-9.11K
$2.56
-$23.31K
Nov 15, 2012
76.62K
Sale
Nov 13 - Nov 14
Form 4
136.17K
$3.53
$278.79K
Jul 23, 2012
136.17K
Grant
Jul 19
Form 4
155.91K
$1.69
$148.93K
Oct 28, 2011
155.91K
Grant
Oct 27
Form 4
5.00K
$3.26
$16.32K
Mar 28, 2011
8.42K
Purchase
Mar 25
Form 4
91.00K
$5.83
$530.53K
Jan 11, 2011
91.00K
Grant
Jan 07
Form 4
1.10M
$0.49
$539.00K
Mar 03, 2010
1.10M
Grant
Mar 01
Form 4
200.00K
$0.56
$112.00K
Mar 02, 2009
200.00K
Grant
Feb 26
Form 4
800.00K
$0.62
$496.00K
Jan 02, 2009
800.00K
Grant
Dec 29
Form 3
Jan 02, 2009
Showing 21 results

CORCEPT THERAPEUTICS INC

Chief Financial Officer
Updated Mar 06, 2006
Form 4
Mar 06, 2006
25.00K
Form 4
50.00%
2.50K
$4.15
$10.38K
Dec 21, 2005
7.50K
Purchase
Dec 20
Form 4
50.00K
$4.82
$241.00K
Jul 08, 2005
50.00K
Grant
Feb 10
Form 4
5.00K
$4.52
$22.60K
Nov 30, 2004
5.00K
Purchase
Nov 29
Form 3
Apr 14, 2004
Showing 5 results

Aridis Pharmaceuticals, Inc.

CFO
Updated Jun 15, 2023
Form 4
12.11%
10.00K
Jun 15, 2023
92.58K
Options
May 04 - Jun 05
Form 4
8.00K
Dec 07, 2022
8.00K
Grant
Dec 05
Form 4
36.65%
20.00K
Oct 05, 2021
74.58K
Grant
Oct 04
Form 4/A
75.30%
17.00K
Aug 29, 2019
39.58K
Grant
Dec 05
Form 3/A
Aug 29, 2019
Form 4
37.90%
15.00K
Aug 01, 2019
54.58K
Grant
Jun 05
Form 4/A
75.31%
17.00K
Dec 12, 2018
39.57K
Grant
Dec 05
Form 4
73.84%
17.00K
Dec 11, 2018
40.02K
Grant
Dec 05
Form 3
Aug 13, 2018
Showing 9 results

GENITOPE CORP

CFO
Updated Oct 27, 2003
Form 3
Oct 27, 2003
73.33K
Showing 1 results